SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(D’Amario Domenico)
 

Search: WFRF:(D’Amario Domenico) > (2019) > Prevalence and Prog...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Savarese, GianluigiKarolinska Institutet,Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden (author)

Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure

  • Article/chapterEnglish2019

Publisher, publication year, extent ...

  • ELSEVIER SCI LTD,2019
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-381568
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-381568URI
  • https://doi.org/10.1016/j.jchf.2018.11.019DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:140584119URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-156193URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies|Swedish Research Council [2013-23897-104604-23, 523-2014-2336]; Swedish Heart Lung Foundation [20120321, 20150557]; Stockholm County Council [20110120]
  • OBJECTIVES: This study sought to evaluate the incidence, the predictors, and the associations with outcomes of changes in ejection fraction (EF) in heart failure (HF) patients.BACKGROUND: EF determines therapy in HF, but information is scarce about incidence, determinants, and prognostic implications of EF change over time.METHODS: Patients with >= 2 EF measurements were made in the Swedish Heart Failure Registry were categorized as heart failure with preserved ejection fraction (HFpEF) (EF >= 50%), heart failure with midrange ejection fraction (HFmrEF) (EF 40% to 49%), or heart failure with reduced ejection fraction (HFrEF) (EF <40%). Changes among categories were recorded, and associations among EF changes, predictors, and all-cause mortality and/or HF hospitalizations were analyzed using logistic and Cox regressions.RESULTS: Of 4,942 patients at baseline, 18% had HFpEF, 19% had HFmrEF, and 63% had HFrEF. During follow-up, 21% and 18% of HFpEF patients transitioned to HFmrEF and HFrEF, respectively; 37% and 25% of HFmrEF patients transitioned to HFrEF and HFpEF, respectively; and 16% and 10% of HFrEF patients transitioned to HFmrEF and HFpEF, respectively. Predictors of increased EF included use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, female sex, cases of less severe HF, and comorbidities. Predictors of decreased EF included diabetes, ischemic heart disease, and cases of more severe HF. Increased EF was associated with a lower risk (hazard ratio [HR]: 0.62; 95% confidence interval [CI]: 0.55 to 0.69) and decreased EF with a higher risk (HR: 1.15; 95% CI: 1.01 to 1.30) of mortality and/or HF hospitalizations. Prognostic implications were most evident for transitions to and from HFrEF.CONCLUSIONS: Increases in EF occurred in one-fourth of HFrEF and HFmrEF patients, and decreases occurred in more than one-third of patients with HFpEF and HFmrEF. EF change was associated with a wide range of important clinical, treatment, and organizational factors as well as with outcomes, particularly transitions to and from HFrEF.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Vedin, OlaUppsala universitet,Institutionen för medicinska vetenskaper,Uppsala kliniska forskningscentrum (UCR),Boehringer Ingelheim AB, Stockholm, Sweden,Uppsala Univ, Sweden; Uppsala Clin Res Ctr, Sweden; Boehringer Ingelheim AB, Sweden(Swepub:uu)olved933 (author)
  • D'Amario, DomenicoUniv Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Inst Cardiol, Inst Sci Res & Treatment, Rome, Italy (author)
  • Uijl, AliciaKarolinska Institutet,Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden; Univ Utrecht, Netherlands (author)
  • Dahlström, UlfLinköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US(Swepub:liu)ulfda85 (author)
  • Rosano, GiuseppeIRCCS San Raffaele Hosp, Dept Med Sci, Rome, Italy (author)
  • Lam, Carolyn S. P.Duke NUS Med Sch, Natl Heart Ctr Singapore, Singapore, Singapore;Univ Med Ctr Groningen, Groningen, Netherlands (author)
  • Lund, Lars H.Karolinska Institutet,Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden (author)
  • Karolinska InstitutetKarolinska Inst, Sweden; Karolinska Univ Hosp, Sweden (creator_code:org_t)

Related titles

  • In:JACC. Heart failure: ELSEVIER SCI LTD7:4, s. 306-3172213-17792213-1787

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view